World Health Organisation. Cardiovascular diseases (CVDs) Fact sheet, update June 2021 https://www.who.int/news-room/fact-sheets/detail/cardiovascular-diseases-(cvds).

Mach F, Baigent C, Catapano AL, et al. 2019 ESC/EAS guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk. Eur Heart J. 2020;41:111–88.

Article  PubMed  Google Scholar 

Libby P, Hansson GK. From focal lipid storage to systemic inflammation: JACC Review topic of the Week. J Am Coll Cardiol. 2019;74:1594–607.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Arnold N, Lechner K, Waldeyer C, Shapiro MD, Koenig W. Inflammation and cardiovascular disease: the future. Eur Cardiol. 2021;16:e20.

Article  PubMed  PubMed Central  Google Scholar 

Peng X, Wu H. Inflammatory links between hypertriglyceridemia and atherogenesis. Curr Atheroscler Rep. 2022;24:297–306.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Watts GF, Gidding SS, Hegele RA, et al. International Atherosclerosis Society guidance for implementing best practice in the care of familial hypercholesterolaemia. Nat Rev Cardiol. 2023;20:845–69.

Article  PubMed  Google Scholar 

Laufs U, Parhofer KG, Ginsberg HN, Hegele RA. Clinical review on triglycerides. Eur Heart J. 2020;41:99–c109.

Article  CAS  PubMed  Google Scholar 

Ginsberg HN, Packard CJ, Chapman MJ, et al. Triglyceride-rich lipoproteins and their remnants: metabolic insights, role in atherosclerotic cardiovascular disease, and emerging therapeutic strategies-a consensus statement from the European Atherosclerosis Society. Eur Heart J. 2021;42:4791–806.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Watts GF, Raal FJ, Chan DC. Transcriptomic therapy for dyslipidemias utilizing nucleic acids targeted at ANGPTL3. Future Cardiol. 2022;18:143–53.

Article  CAS  PubMed  Google Scholar 

Mohamed F, Mansfield BS, Raal FJ. ANGPTL3 as a drug target in hyperlipidemia and atherosclerosis. Curr Atheroscler Rep. 2022;24:959–67.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Kersten S. ANGPTL3 as therapeutic target. Curr Opin Lipidol. 2021;32:335–41.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Thorin E, Labbé P, Lambert M, Mury P, Dagher O, Miquel G, Thorin-Trescases N. Angiopoietin-like proteins: Cardiovascular biology and therapeutic targeting for the prevention of cardiovascular diseases. Can J Cardiol. 2023;39:1736–56.

Article  PubMed  Google Scholar 

Morelli MB, Chavez C, Santulli G. Angiopoietin-like proteins as therapeutic targets for cardiovascular disease: focus on lipid disorders. Expert Opin Ther Targets. 2020;24:79–88.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Kersten S. Angiopoietin-like 3 in lipoprotein metabolism. Nat Rev Endocrinol. 2017;13:731–9.

Article  CAS  PubMed  Google Scholar 

Lupo MG, Ferri N. Angiopoietin-like 3 (ANGPTL3) and atherosclerosis: lipid and non-lipid related effects. J Cardiovasc Dev Dis. 2018;5:39.

CAS  PubMed  PubMed Central  Google Scholar 

Luo M, Peng D. ANGPTL8: an important regulator in metabolic disorders. Front Endocrinol (Lausanne). 2018;9:169.

Article  PubMed  Google Scholar 

Abu-Farha M, Ghosh A, Al-Khairi I, Madiraju SRM, Abubaker J, Prentki M. The multi-faces of Angptl8 in health and disease: novel functions beyond lipoprotein lipase modulation. Prog Lipid Res. 2020;80:101067.

Article  CAS  PubMed  Google Scholar 

Yang J, Song QY, Niu SX, Chen HJ, Petersen RB, Zhang Y, Huang K. Emerging roles of angiopoietin-like proteins in inflammation: mechanisms and potential as pharmacological targets. J Cell Physiol. 2022;237:98–117.

Article  CAS  PubMed  Google Scholar 

Guo C, Zhao Z, Deng X, Chen Z, Tu Z, Yuan G. Regulation of angiopoietin-like protein 8 expression under different nutritional and metabolic status. Endocr J. 2019;66:1039–46.

Article  CAS  PubMed  Google Scholar 

Sylvers-Davie KL, Davies BSJ. Regulation of lipoprotein metabolism by ANGPTL3, ANGPTL4, and ANGPTL8. Am J Physiol Endocrinol Metab. 2021;321:E493–508.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Kersten S. Role and mechanism of the action of angiopoietin-like protein ANGPTL4 in plasma lipid metabolism. J Lipid Res. 2021;62:100150.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Chen YQ, Pottanat TG, Siegel RW, et al. Angiopoietin-like protein 8 differentially regulates ANGPTL3 and ANGPTL4 during postprandial partitioning of fatty acids. J Lipid Res. 2020;61:1203–20.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Haller JF, Mintah IJ, Shihanian LM, et al. ANGPTL8 requires ANGPTL3 to inhibit lipoprotein lipase and plasma triglyceride clearance. J Lipid Res. 2017;58:1166–73.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Kovrov O, Kristensen KK, Larsson E, Ploug M, Olivecrona G. On the mechanism of angiopoietin-like protein 8 for control of lipoprotein lipase activity. J Lipid Res. 2019;60:783–93.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Balasubramaniam D, Schroeder O, Russell AM, et al. An anti-ANGPTL3/8 antibody decreases circulating triglycerides by binding to a LPL-inhibitory leucine zipper-like motif. J Lipid Res. 2022;63:100198.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Yang Y, Beigneux AP, Song W, et al. Hypertriglyceridemia in Apoa5-/- mice results from reduced amounts of lipoprotein lipase in the capillary lumen. J Clin Invest. 2023;133:e172600.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Zhang R, Zhang K. An updated ANGPTL3-4-8 model as a mechanism of triglyceride partitioning between fat and oxidative tissues. Prog Lipid Res. 2022;85:101140.

Article  CAS  PubMed  Google Scholar 

Dewey FE, Gusarova V, Dunbar RL, et al. Genetic and pharmacologic inactivation of ANGPTL3 and cardiovascular disease. N Engl J Med. 2017;377:211–21.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Quagliarini F, Wang Y, Kozlitina J, et al. Atypical angiopoietin-like protein that regulates ANGPTL3. Proc Natl Acad Sci U S A. 2012;109:19751–6.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Hanson RL, Leti F, Tsinajinnie D, et al. The Arg59Trp variant in ANGPTL8 (betatrophin) is associated with total and HDL-cholesterol in American indians and Mexican americans and differentially affects cleavage of ANGPTL3. Mol Genet Metab. 2016;118:128–37.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Hou G, Tang Y, Ren L et al. The ANGPTL8 rs2278426 (C/T) polymorphism is associated with prediabetes and type 2 diabetes in a Han Chinese population in Hebei Province. Int J Endocrinol. 2020;2020:1621239.